Form 8-K - Current report:
SEC Accession No. 0001808665-21-000038
Filing Date
2021-05-06
Accepted
2021-05-06 16:09:28
Documents
16
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asrt-20210506.htm   iXBRL 8-K 40379
2 EX-99.1 asrt1q2021earningsreleasee.htm EX-99.1 163782
8 image0a061.jpg GRAPHIC 3999
  Complete submission text file 0001808665-21-000038.txt   375761

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20210506.xsd EX-101.SCH 2501
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20210506_cal.xml EX-101.CAL 783
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20210506_def.xml EX-101.DEF 1739
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20210506_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20210506_pre.xml EX-101.PRE 13263
9 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20210506_htm.xml XML 10985
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 21897810
SIC: 2834 Pharmaceutical Preparations